Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 06 Feb 2025 for Revance Therapeutics, Inc., €101k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Chris Nolet: trading record in brief
This profile gathers the share dealings of Chris Nolet across 3 companies, led by Revance Therapeutics, Inc., Polarityte, Inc. and Jasper Therapeutics, Inc. In total, 8 filings cover trades dated from 5 May 2021 to 4 February 2025.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 6 February 2025 with a transaction (€101k) in Revance Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Chris Nolet
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
28,606 shares@ US$3.65100.0% of flowCommon StockSEC:0000950170-25-015339:0
15,000 shares0Common StockSEC:0001479290-24-000088:0
3,534 shares0Common StockSEC:0001479290-23-000062:0
36,497 shares0Common StockSEC:0001493152-23-001628:0
32,500 shares0Voting Common StockSEC:0001213900-22-063938:0
50,900 shares0Common StockSEC:0001493152-22-027578:0
6,059 shares0Common StockSEC:0001479290-22-000063:0
4,013 shares0Common StockSEC:0001479290-21-000112:0
8 of 8 declarations
